http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2017003040-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a73cee5001ad08339ae751c10d9abf71
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
filingDate 2017-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ddcf480314c3f0950f7687d8d2bb248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4cca54cb92caeb82f271a3035129e9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d7b41c1c8a309e39d138b9ca86ca757
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5767af322ba5391c7f7c24203a5167a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5aa9adb79b91cc60a0082ed1f17b426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fae0860d5ee0ce6585886f9bd1fb7cd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b132d36eb2519e6fc743d9f1059fbae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9c4f2c5129515a72d935373151fd98c
publicationDate 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2017003040-A1
titleOfInvention Cyclopropylamine as an inhibitor of lsd1 (divisional of application 2027-2016).
abstract <p> THIS INVENTION IS DIRECTED TO CICLOPROPILAMINE DERIVATIVES THAT ARE INHIBITORS OF THE EFFECTIVE LSD1 FOR THE TREATMENT OF DISEASES LIKE CANCER. </p>
priorityDate 2014-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457560897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69828

Total number of triples: 28.